HAELO

Serial Number 98463858
653

Registration Progress

Application Filed
Mar 22, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

HAELO

Basic Information

Serial Number
98463858
Filing Date
March 22, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
653
Status Date
Apr 7, 2025
Application
Pending
Classes
035 042 044

Rights Holder

Intellia Therapeutics, Inc.

03
Address
40 Erie Street
Cambridge, MA 02139

Ownership History

Intellia Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Legal Representation

Attorney
Jonathan M. Gelchinsky

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Apr 7, 2025 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 7, 2025 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Apr 7, 2025 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 3, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 3, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 3, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 13, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Dec 13, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Oct 7, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 7, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 7, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 1, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 20, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 20, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 22, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the treatment of hereditary angioedema (HAE) using in vivo gene editing technology
Class 042
Scientific research in the nature of conducting clinical trials for others for the treatment of hereditary angioedema (HAE) using in vivo gene editing technology
Class 044
Medical treatment of hereditary angioedema (HAE) using in vivo gene editing technology

Additional Information

Design Mark
The mark consists of the stylized word "HAELO" with "HAE" in blue and "LO" in light blue, with two rows of small rectangular shapes forming two semi-circles appearing above, the top row in yellow and the bottom row in red-orange. The white in the mark represents background and is not a feature of the mark.
Color Claim
The color(s) blue, light blue, yellow, and red-orange is/are claimed as a feature of the mark.

Classification

International Classes
035 042 044